Multi-institutional feasibility study of intensity-modulated radiotherapy with chemotherapy for locally advanced non-small cell lung cancer

Background This multi-institutional clinical trial evaluated the feasibility of intensity-modulated radiotherapy (IMRT) for patients with locally advanced non-small cell lung cancer (NSCLC). Methods The major inclusion criteria were clinical stage III NSCLC, age 20–74 years, and Eastern Cooperative...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of clinical oncology 2022-06, Vol.27 (6), p.1025-1033
Hauptverfasser:	Harada, Hideyuki, Omori, Shota, Mori, Keita, Konno, Masahiro, Murakami, Haruyasu, Imagumbai, Toshiyuki, Fukuda, Haruyuki, Nakamatsu, Kiyoshi, Kimura, Tomoki, Tanabe, Hiroaki, Fujita, Hideki, Tatebe, Hitoshi, Fujitaka, Kazunori, Nishimura, Yasumasa
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Cancer Research Carboplatin Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - radiotherapy Chemoradiotherapy - adverse effects Chemoradiotherapy - methods Chemotherapy Cisplatin Cisplatin - therapeutic use Confidence intervals Feasibility Studies Humans Lung cancer Lung Neoplasms - drug therapy Lung Neoplasms - radiotherapy Medicine Medicine & Public Health Middle Aged Non-small cell lung carcinoma Oncology Original Article Paclitaxel Paclitaxel - adverse effects Patients Pneumonitis Quality assurance Radiation therapy Radiotherapy, Intensity-Modulated - adverse effects Radiotherapy, Intensity-Modulated - methods Small cell lung carcinoma Surgical Oncology Thorax Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!